Filed: 7/18/2025ACC: 0001999371-25-009410
📋 What this filing means
WILDCAT CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $168.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$168.31M
Total AUM (reported)
51.14M
Total Shares
Allocation by class
COM$128.33M76.2%
SPONSORED ADS$39.88M23.7%
SHS NEW$91.9K0.1%
Portfolio Concentration
Top 3$158.30M94.1%
4–10$10.00M5.9%
Top 3 weight
94.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 51.14M
Sole
Full voting authority
51.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
FRONTIER GROUP HLDGS INC
SOLEShares28.06M
TypeSH
Market value$101.86M
60.52%
Sole
28.06M
Shared
0.00
None
0.00
RLX TECHNOLOGY INC
SOLEShares18.05M
TypeSH
Market value$39.88M
23.70%
Sole
18.05M
Shared
0.00
None
0.00
ACUREN CORP
SOLEShares1.50M
TypeSH
Market value$16.56M
9.84%
Sole
1.50M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares495.61K
TypeSH
Market value$6.79M
4.03%
Sole
495.61K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares2.92M
TypeSH
Market value$3.12M
1.85%
Sole
2.92M
Shared
0.00
None
0.00
SILEXION THERAPEUTICS CORP
SOLEShares113.43K
TypeSH
Market value$91.9K
0.05%
Sole
113.43K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
FRONTIER GROUP HLDGS INCSOLE | COM | 28.06M | SH | $101.86M 60.52% | 28.06M | 0.00 | 0.00 |
RLX TECHNOLOGY INCSOLE | SPONSORED ADS | 18.05M | SH | $39.88M 23.70% | 18.05M | 0.00 | 0.00 |
ACUREN CORPSOLE | COM | 1.50M | SH | $16.56M 9.84% | 1.50M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 495.61K | SH | $6.79M 4.03% | 495.61K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 2.92M | SH | $3.12M 1.85% | 2.92M | 0.00 | 0.00 |
SILEXION THERAPEUTICS CORPSOLE | SHS NEW | 113.43K | SH | $91.9K 0.05% | 113.43K | 0.00 | 0.00 |